Analyst firms · BofA Securities · ALKS
BofA Securities ALKS price target and rating history
Alkermes plc (ALKS) · Health Care
BofA Securities rates Alkermes plc (ALKS) Underperform with a $38 price target, as of its latest action on Jun 29, 2026. It has published 3 rating actions on ALKS since September 2021, including 1 upgrade and 2 downgrades. Across 3 firms with a ALKS price target in the last 12 months, the median target is $45. BofA Securities's $38 is 16% below that.
- Current rating
- Underperform
- Price target
- $38
- Median target, all firms
- $45
- Actions on ALKS
- 3
BofA Securities price target on ALKS
Every BofA Securities rating on ALKS
- Jun 29, 2026
- Oct 14, 2022
- Sep 2, 2021
How other firms rate ALKS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Truist Securities | Buy | $55 | Oct 16, 2026 |
| BofA Securities | Underperform | $38 | Jun 29, 2026 |
| Wolfe Research | Outperform | $45 | Feb 24, 2026 |
Questions about BofA Securities and ALKS
- What is BofA Securities's price target for ALKS?
- BofA Securities's latest stated price target for Alkermes plc (ALKS) is $38, from its action on Jun 29, 2026.
- What is BofA Securities's rating on ALKS?
- BofA Securities rates ALKS Underperform, a bearish rating, as of Jun 29, 2026.
- When did BofA Securities last change its view on ALKS?
- On Jun 29, 2026, BofA Securities downgrades to Underperform from Neutral, price target $38.
- How does BofA Securities's ALKS target compare with other analysts?
- Across 3 firms with a ALKS price target in the last 12 months, the median target is $45. BofA Securities's $38 is 16% below that.
More ALKS rating histories
All BofA Securities ratingsALKS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.